Compare MDLN & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDLN | LH |
|---|---|---|
| Founded | 1966 | 1971 |
| Country | United States | United States |
| Employees | N/A | 70000 |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.7B | 30.2B |
| IPO Year | 2025 | 2005 |
| Metric | MDLN | LH |
|---|---|---|
| Price | $42.20 | $371.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 27 | 17 |
| Target Price | $45.31 | ★ $390.06 |
| AVG Volume (30 Days) | ★ 9.8M | 722.9K |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | 0.45 | ★ 10.22 |
| Revenue | ★ $28,432,000,000.00 | $13,951,700,000.00 |
| Revenue This Year | $10.44 | $6.24 |
| Revenue Next Year | $8.03 | $5.37 |
| P/E Ratio | $91.29 | ★ $36.39 |
| Revenue Growth | ★ 11.47 | 7.25 |
| 52 Week Low | $31.37 | $245.00 |
| 52 Week High | $50.88 | $373.76 |
| Indicator | MDLN | LH |
|---|---|---|
| Relative Strength Index (RSI) | 75.32 | 71.17 |
| Support Level | $40.90 | $256.51 |
| Resistance Level | $43.31 | N/A |
| Average True Range (ATR) | 1.59 | 11.04 |
| MACD | 0.88 | 2.03 |
| Stochastic Oscillator | 95.51 | 94.48 |
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.